{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:00:02Z","timestamp":1770822002015,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/s10434-999-0582-6","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T23:49:18Z","timestamp":1109375358000},"page":"582-590","source":"Crossref","is-referenced-by-count":136,"title":["Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)"],"prefix":"10.1007","volume":"6","author":[{"given":"Bernard J.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Royalty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen C.","family":"Kranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1053","volume":"78","author":"RR Connelly","year":"1987","unstructured":"Connelly RR, Spirtas R, Myers MH, et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 1987; 78:1053.","journal-title":"J Natl Cancer Inst"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4613-1245-1_17","volume":"81","author":"AM Averbach","year":"1996","unstructured":"Averbach AM, Sugarbaker PH. Peritoneal mesothelioma: treatment approach based on natural history. Cancer Treat Res 1996; 81:193?211.","journal-title":"Cancer Treat Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000199880","volume":"43","author":"T van Gelder","year":"1989","unstructured":"van Gelder T, Hoogsteden HC, Versnel MA, et al. Malignant peritoneal mesothelioma: a series of 19 cases. Digestion 1989;43: 222?227.","journal-title":"Digestion"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0016-5085(19)33323-2","volume":"63","author":"C Moertel","year":"1972","unstructured":"Moertel C. Peritoneal mesothelioma. Gastroenterology 1972;63: 346?350.","journal-title":"Gastroenterology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9343(80)90103-5","volume":"68","author":"KH Antman","year":"1980","unstructured":"Antman KH, Blum RH, Greenberger JS, et al. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980;68:356?62.","journal-title":"Am J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1988.6.1.147","volume":"6","author":"K Antman","year":"1988","unstructured":"Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana Farber Cancer Institute and Brigham and Women?s Hospital experience over two decades, 1965?1985. J Clin Oncol 1988;6:147?53.","journal-title":"J Clin Oncol"},{"key":"CR7","first-page":"1399","volume-title":"Cancer: Principles and practice of oncology","author":"KH Antman","year":"1989","unstructured":"Antman KH, Pass HI, Recht A. Benign and malignant mesothelioma. In: DeVita V, Hellman S, Rosenberg S, eds. Cancer: Principles and practice of oncology. Philadelphia: Lippincott, 1989: 1399?1417."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archsurg.1988.01400300109019","volume":"123","author":"WJ Plaus","year":"1988","unstructured":"Plaus WJ. Peritoneal mesothelioma. Arch Surg 1988;123:763?766.","journal-title":"Arch Surg"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00944192","volume":"10","author":"G Falkson","year":"1992","unstructured":"Falkson G, Hunt M, Borden EC, et al. An extended phase II trial of ifosfamide plus mesma in malignant mesothelioma. Invest New Drugs 1992;10:337?343.","journal-title":"Invest New Drugs"},{"key":"CR10","first-page":"1","volume":"XII","author":"RL Dedrick","year":"1985","unstructured":"Dedrick RL. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985;XII:1?6.","journal-title":"Semin Oncol"},{"key":"CR11","first-page":"86","volume":"22","author":"M Markman","year":"1995","unstructured":"Markman M. Intraperitoneal paclitaxel in the management of ovarian cancer. Semin Oncol 1995;22:86?87.","journal-title":"Semin Oncol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(85)90526-4","volume":"2","author":"K Antman","year":"1985","unstructured":"Antman K, Osteen R, Klegar K, et al. Early peritoneal mesothelioma: a treatable malignancy. Lancet 1985;2:977?981.","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19870601)59:11<1882::AID-CNCR2820591107>3.0.CO;2-0","volume":"59","author":"GS Lederman","year":"1987","unstructured":"Lederman GS, Recht A, Herman T, et al. Long-term survival in peritoneal mesothelioma: the role of radiotherapy and combined modality treatment. Cancer 1987;59:1882?6.","journal-title":"Cancer"},{"key":"CR14","first-page":"2","volume":"8","author":"HR Alexander","year":"1995","unstructured":"Alexander HR, Fraker DL. Continuous hyperthermic peritoneal perfusion with cisplatin in the treatment of peritoneal carcinomatosis. Reg Cancer Treat 1995;8:2?7.","journal-title":"Reg Cancer Treat"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","volume":"208","author":"S Fujimoto","year":"1988","unstructured":"Fujimoto S, Shgrestha RD, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36?41.","journal-title":"Ann Surg"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-0142(19900101)65:1<65::AID-CNCR2820650115>3.0.CO;2-L","volume":"65","author":"T Fujimura","year":"1990","unstructured":"Fujimura T, Yonemura Y, Fushida S, et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65?71.","journal-title":"Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232?237.","journal-title":"Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1251::AID-CNCR27>3.0.CO;2-3","volume":"83","author":"DL Bartlett","year":"1998","unstructured":"Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer 1998;83:1251?1261.","journal-title":"Cancer"},{"key":"CR19","first-page":"174","volume":"3","author":"GY Ma","year":"1997","unstructured":"Ma GY, Bartlett DL, Reed E, et al. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J Sci Am 1997;3:174?179.","journal-title":"Cancer J Sci Am"},{"key":"CR20","first-page":"1","volume-title":"Principles and practices of oncology updates","author":"HR Alexander","year":"1995","unstructured":"Alexander HR, Buell JF, Fraker DL. Rationale and clinical status of continuous hyperthermic peritoneal perfusion (CHPP) for the treatment of peritoneal carcinomatosis. In: DeVita V, Hellman S, Rosenberg S, eds. Principles and practices of oncology updates. Philadelphia: J.B. Lippincott, 1995:1?9."},{"key":"CR21","first-page":"1426","volume":"43","author":"SB Howell","year":"1983","unstructured":"Howell SB, Pfeifle CE, Wung WE, et al. Intraperitoneal cisdiamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 1983;43:1426?1431.","journal-title":"Cancer Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-97-6-845","volume":"97","author":"SB Howell","year":"1982","unstructured":"Howell SB, Pfeifle CG, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982;97:845?851.","journal-title":"Ann Intern Med"},{"key":"CR23","first-page":"64","volume":"19","author":"NJ Vogelzang","year":"1992","unstructured":"Vogelzang NJ. Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 1992;19:64?71.","journal-title":"Semin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/archsurg.1990.01410230071012","volume":"125","author":"JA Asensio","year":"1990","unstructured":"Asensio JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. Arch Surg 1990;125:1477?1481.","journal-title":"Arch Surg"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/1097-0142(19860701)58:1<18::AID-CNCR2820580105>3.0.CO;2-C","volume":"58","author":"M Markman","year":"1986","unstructured":"Markman M, Cleary S, Pfeifle C, et al. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma. Cancer 1986;58:18?21.","journal-title":"Cancer"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01225271","volume":"118","author":"M Markman","year":"1992","unstructured":"Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 1992;118:547?550.","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR27","first-page":"124","volume":"41","author":"FN Gilly","year":"1994","unstructured":"Gilly FN, Carry PY, Sayag AC, et al. Regional chemotherapy (with Mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124?129.","journal-title":"Hepatogastroenterology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","volume":"18","author":"T Fujimura","year":"1994","unstructured":"Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994;18:150?155.","journal-title":"World J Surg"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0039-6060(96)80145-0","volume":"119","author":"Y Yonemura","year":"1996","unstructured":"Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437?444.","journal-title":"Surgery"},{"key":"CR30","first-page":"84","volume":"16","author":"P Canal","year":"1989","unstructured":"Canal P, de Forni M, Chatelut E, et al. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg\/m2 alone or 200 mg\/m2 with i.v. sodium thiosulfate. JAMA 1989;16:84?86.","journal-title":"JAMA"},{"key":"CR31","first-page":"1165","volume":"40","author":"B Barlogie","year":"1980","unstructured":"Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-Dichlorodiammineplatinum(II) and Mitomycin C. Cancer Res 1980;40:1165?1168.","journal-title":"Cancer Res"},{"key":"CR32","first-page":"46","volume":"22","author":"JA Ajani","year":"1995","unstructured":"Ajani JA, Ilson DH, Kelsen DP. The activity of paclitaxel in gastrointestinal tumors. Semin Oncol 1995;22:46?50.","journal-title":"Semin Oncol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1200\/JCO.1987.5.10.1607","volume":"5","author":"SB Howell","year":"1987","unstructured":"Howell SB, Zimm S, Markman M, et al. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol 1987;5:1607?1612.","journal-title":"J Clin Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mpo.2950190420","volume":"19","author":"E Schwartz","year":"1991","unstructured":"Schwartz E, Maayan C, Mouallem M, et al. Malignant peritoneal mesothelioma: long-term spontaneous clinical remission. Med Pediatr Oncol 1991;19:325?328.","journal-title":"Med Pediatr Oncol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5694\/j.1326-5377.1989.tb136324.x","volume":"150","author":"PE Norman","year":"1989","unstructured":"Norman PE, Whitaker D. Nine-year survival in a case of untreated peritoneal mesothelioma. Med J Aust 1989;150:43?44.","journal-title":"Med J Aust"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-999-0582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0582-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:04:09Z","timestamp":1586131449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-999-0582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s10434-999-0582-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}